Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced another successful readout for its ECD program, which is evaluating a blood-based screening test for the ...

It was a weaker, er, week for healthcare stocks on the ASX, but takeover bids, trials and expansion deals kept the sector’s ...

Crisis pregnancy centers, or anti-abortion organizations that try to prevent customers from accessing abortion and ...

Our ratings take into account the card’s rewards, fees, rates along with the card’s category. All ratings are determined solely by our editorial team. Jessica is a former writer and editor at Forbes ...